Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forest Clinical Trials Registry Launches With Antidepressant Data

This article was originally published in The Pink Sheet Daily

Executive Summary

Forest's registry website, required under a settlement with the New York Attorney General, currently includes summaries of pediatric and adolescent studies of Lexapro and Celexa, and listings for all of Forest's open Phase III and IV trials.
Advertisement

Related Content

Desmoteplase Approval For Stroke Expected In 2009, Forest Says
Desmoteplase Approval For Stroke Expected In 2009, Forest Says
Forest Settles With Spitzer, Will Post All Phase III-IV Results On-Line
Forest Settles With Spitzer, Will Post All Phase III-IV Results On-Line

Topics

Advertisement
UsernamePublicRestriction

Register

PS061683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel